HealthDay (5/7, Gotkine) reported a study found that the “prevalence of depressive symptoms increased among U.S. adults during the pandemic.” Researchers “examined changes in depressive symptoms among U.S. adults overall and across sociodemographic characteristics using 2013 to 2023 National Health and Nutrition Examination Survey data.” They found “the observed prevalence of depressive symptoms increased from 8.2 to 12.3 percent from 2013-2020 to 2021-2023.” In addition, “depressive symptom prevalence increased by 3.5 percentage points during the pandemic after adjustment and accounting for secular trends.” There was also “a significantly larger increase seen in the prevalence of depressive symptoms among adults aged 20 to 44 years versus those aged 65 years or older” between 2013-2020 and 2021-2023. The study was published in JAMA Internal Medicine (SOURCE: APA Headlines)